IPO details · Updated
Q-Line Biotech Limited
- Price Band
- ₹326 – ₹343
- Lot Size
- 400 shares
- Min. Investment
- ₹1,37,200
- Issue Size
- ₹214.48 Cr
- Offer Dates
- 21 May – 25 May 2026
- Listing
- 29 May 2026
Issue Details
- Total Issue Size
- ₹214.48 Cr
- 62,53,200 shares
- Fresh Issue
- ₹214.48 Cr
- 62,53,200 shares
- Offer for Sale
- ₹0 Cr
- Face Value
- ₹10 per share
- Issue Type
- Book-built IPO
- Listing At
- NSE SME
- Shares Pre-Issue
- 1,70,74,999
- Shares Post-Issue
- 2,33,28,199
IPO Timeline
Offer opens
21 May 2026
Offer closes
25 May 2026
Allotment
26 May 2026
Listing
29 May 2026
Issue Allocation
Share of the offer reserved for each investor category
- Anchor28.5%17,81,200 shares
- QIB19.0%11,88,000 shares
- HNI14.3%8,91,600 shares
- Retail33.3%20,79,200 shares
- MarketMaker5.0%3,13,200 shares
Subscription Status
Times subscribed by investor category
| Category | Offered | Bids | Subscribed |
|---|---|---|---|
| QIB | 11,88,000 | 14,72,40,720 | 123.94x |
| NII | 8,91,600 | 13,01,55,768 | 145.98x |
| Retail | 20,79,200 | 14,85,38,048 | 71.44x |
| Total | 41,58,800 | 42,59,34,536 | 102.42x |
Lot Size & Investment
1 lot = 400 shares
Retail (min)
2 lots · 800 shares
Retail (max)
2 lots · 800 shares
S-HNI (min)
3 lots · 1,200 shares
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail | 2 | 800 | ₹2,74,400 |
| Small HNI (S-HNI) | 3 | 1,200 | ₹4,11,600 |
| Big HNI (B-HNI) | 8 | 3,200 | ₹10,97,600 |
Financial Performance
Restated figures in ₹ crore, unless stated otherwise
| Period | Dec-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| Assets | 561.34 | 455.49 | 339.25 | 251.58 |
| Total Income | 236.5 | 322.58 | 206.45 | 184.81 |
| Profit After Tax | 38.69 | 28.13 | 34.44 | 32.1 |
| EBITDA | 64.23 | 71.32 | 37.63 | 32.98 |
| Net Worth | 229.16 | 189.95 | 161.81 | 127.37 |
| Reserves & Surplus | 212.89 | 188.37 | 160.24 | 125.79 |
| Total Borrowing | 243.85 | 164.95 | 96.91 | 73.65 |
Key Performance Indicators
| Period | Dec-25 | Mar-25 |
|---|---|---|
| ROE (%) | 16.88 | 23.74 |
| ROCE (%) | 13.32 | 17.66 |
| EPS (₹) | — | 16.47 |
| P/E (pre-issue) | — | 20.82 |
| P/E (post-issue) | — | 15.51 |
About Q-Line Biotech Limited
Incorporated in 2010, Q-Line Biotech Ltd. is engaged in the business of developing, manufacturing and marketing a diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, and distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs since 2013 directly or through our distributor/s majorly to diagnostic service providers, hospitals and medical colleges. The company's key manufacturing segments include indigenous manufacturing of reagents (Clinical Chemistry, Haematology, Immunodiagnostics, Molecular Diagnostics, and Others [POC Devices & Rapid Tests]) and supplying/manufacturing of in-vitro diagnostics (IVD) and Pathology equipment & devices. As of December 31, 2025, the total annual capacity was about 1.4 million kits (Haematology, Clinical Chemistry, Rapid/Elisa) and 1,200 Selectra Machines. As on March 31, 2026, the company had 362 permanent employees. Competitive Strengths : Established manufacturing capabilities with focus on R&D, Reverse Engineering and quality control. Diversified product portfolio with focus on IVD industry Widespread distribution network with a presence across all four regions. Long standing relationships with customers. Experienced Promoter and Management team
Objects of the Issue
- To meet working capital requirements (₹93.50 Cr)
- Repayment of certain borrowing availed by the Company, in part or full (₹90.00 Cr)
- General Corporate Purposes (₹5.10 Cr)
- Issue Expenses (₹25.89 Cr)
Promoters
- Saurabh Garg
- Amita Garg
- Ayush Garg
- Ajay Kumar Mahanty
- Abhay Agrawal
Company Information
- Book running lead managers
- Hem Securities Ltd.
- Share India Capital Services Pvt.Ltd.
- Registered office
- 298-281, Transport Nagar, Kanpur Road Adjacent Transport Nagar Metro Station, Lucknow, Uttar Pradesh, 226012
- Market maker
- Hem Finlease Pvt.Ltd.
Official Documents
Opens the source filing in a new tab
Similar IPOs
Disclaimer: Data on OpenIPO is for information only and is not investment advice. OpenIPO is not a SEBI-registered entity. GMP figures are unofficial estimates and may change. Verify all details against the company RHP and the official registrar before investing.